Ownership

John Hamill - SrVP/CFO/Prin Fin & Acct Ofcr at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: SrVP/CFO/Prin Fin & Acct Ofcr
Stock Symbol: APRE on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

John Hamill - trading volume in the past year for Aprea Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+1.51K	100%	$5.74	+$8.66K
Sells
Net	+1.51K	100%		+$8.66K

Holdings reported by John Hamill for Aprea Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	19.4K	$47.7K	$2.46	Oct 11, 2024	Direct
Stock Options (Right to Buy)	13.5K			Mar 28, 2024	Direct	Common Stock
Tranche A Warrant	505			Mar 13, 2024	Direct	Common Stock
Tranche B Warrant	505			Mar 13, 2024	Direct	Common Stock

Transactions reported by John Hamill for Aprea Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.